COMPASS THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $9.3M | $-70.6K | $4.9K |
| FY2020 | $1.9M | $-108.1K | $3.7K |
| FY2021 | $0 | $140.1M | $144.5M |
| FY2022 | — | $181.6M | $34.9M |
| FY2023 | — | $148.5M | $24.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $9.3M | $-70.6K | $4.9K |
| FY2020 | $1.9M | $-108.1K | $3.7K |
| FY2021 | $0 | $140.1M | $144.5M |
| FY2022 | — | $181.6M | $34.9M |
| FY2023 | — | $148.5M | $24.2M |